Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode Schizophrenia. [PDF]
Neuropsychiatr Dis TreatHu W +10 more
europepmc +1 more source
Positive and Negative Symptoms Changes in Schizophrenia Patients on Antipsychotic Treatment: a Systematic Review and Dose-Response Meta-analysis. [PDF]
Schizophr BullLin X +6 more
europepmc +1 more source
Preventive effects of active Protocol-Based Pharmacotherapy Management for delirium in general wards of emergency department (aPBPM trial): study protocol for a single-center, randomized controlled trial {1a}. [PDF]
TrialsTakatani Y +9 more
europepmc +1 more source
Intracranial hypertension after MECT: successful transition to rTMS for refractory auditory hallucinations: a case report. [PDF]
Front PsychiatryLv L, Guan MY.
europepmc +1 more source
Structure-based design of subtype-selective psychedelic analogs. [PDF]
Nat CommunLi H +10 more
europepmc +1 more source
Blonanserin versus risperidone for schizophrenia
Cochrane Database of Systematic Reviews, 2017 Tarek Turk +2 more
openaire +2 more sources
Meta-Analysis of the Effect of Blonanserin in Treating Patients with Schizophrenia. [PDF]
Noro Psikiyatr ArsShi B +5 more
europepmc +1 more source
Effectiveness and safety of blonanserin monotherapy for first-episode schizophrenia with and without prominent negative symptoms: A prospective study. [PDF]
World J PsychiatryChen LH +9 more
europepmc +1 more source
Neurological Adverse Effects of Antipsychotic Medication in Children and Young People. [PDF]
Paediatr DrugsBesag FMC, Vasey MJ, Hollis C, Taylor D.
europepmc +1 more source